Devising a best practice approach to prophylaxis in boys with severe haemophilia: evaluation of current treatment strategies.
Data from prospective studies clearly demonstrate the efficacy of prophylactic treatment of haemophilia in reducing joint- or life-threatening bleeding and the associated consequences for quality of life. Debate remains, however, regarding the optimal implementation of prophylaxis. Our aim in this review was to identify a best practice approach to factor replacement prophylaxis in boys with haemophilia. We evaluate prophylactic treatment regimens currently used in Swedish, Canadian and French centres and highlight key issues, including the optimal age for starting prophylaxis, the optimal treatment dosage/schedule and patient compliance.
Division of Hematology/Oncology, Hospital for Sick Children, Toronto, ON, Canada. manuel.carcao@sickkids.on.ca
M
M
Carcao
H
H
Chambost
R
R
Ljung
D000293:Adolescent; D000367:Age Factors; D001779:Blood Coagulation Factors / Q000008:administration & dosage*; D002170:Canada; D002648:Child; D002675:Child, Preschool; D004334:Drug Administration Schedule; D005602:France; D006395:Hemarthrosis / Q000517:prevention & control; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D008297:Male; D010349:Patient Compliance; D013548:Sweden
D001779:Blood Coagulation Factors